Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 10,177 | 9,250 | 7,871 | 4,366 | 5,062 |
| Operating Income | -10,177 | -9,250 | -7,871 | -4,366 | -5,062 |
| Interest Expense | 1,510 | 1,354 | 1,215 | 1,304 | 1,237 |
| Other Income | 342 | 1,133 | 901 | 1,719 | -476 |
| Pre-tax Income | -11,345 | -9,471 | -8,185 | -3,951 | -6,775 |
| Net Income Continuous | -11,345 | -9,471 | -8,185 | -3,951 | -6,775 |
| Net Income | $-11,345 | $-9,471 | $-8,185 | $-3,951 | $-6,775 |
| EPS Basic Total Ops | -1.03 | -0.86 | -0.74 | 0.12 | -3.94 |
| EPS Basic Continuous Ops | -1.03 | -0.86 | -0.74 | -0.21 | -3.83 |
| EPS Diluted Total Ops | -1.03 | -0.86 | -0.74 | 0.12 | -3.94 |
| EPS Diluted Continuous Ops | -1.03 | -0.86 | -0.74 | -0.21 | -3.83 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -0.86 | -0.74 | N/A | -2.19 |
| EBITDA(a) | $-10,177 | $-9,250 | $-7,871 | $-4,366 | $-5,062 |